IP Library Granted Patent US 7,807,192
Granted Patent B2
US 7,807,192 · App. 10/971,435 · Granted Oct 5, 2010

Biopolymeric membranes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,807,192
App. No.
10/971,435
Granted
Oct 5, 2010
Kind
B2
Abstract

This invention relates to a sheet membrane for repairing a damaged tissue. The membrane includes an isotropic layer of cross-linked biopolymeric fibers in which the fibers are 10 to 1,000 cm in length. This invention also relates to a method of making an isotropic layer of cross-linked biopolymeric fibers. The method includes: (1) coacervating biopolymeric fibers (e.g., collagen-based fibers) having lengths of less than 1 cm dispersed in an aqueous solution to obtain coacervated biopolymeric fibers having lengths of 10 to 1,000 cm; (2) flattening the coacervated biopolymeric fibers into a layer; (3) drying the layer; and (4) cross-linking the biopolymeric.

Claims (18)

1. A sheet membrane for repairing a damaged tissue, comprising an isotropic layer of cross-linked biopolymeric fibers, wherein the fibers are 10 to 1,000 cm in length and the membrane is permeable to molecules having molecular weights of 50 to 100,000 daltons.

2. The sheet membrane of claim 1 , wherein the biopolymeric fibers are collagen-based fibers.

3. The sheet membrane of claim 1 , wherein the biopolymeric fibers are 30 to 800 cm in length.

4. The sheet membrane of claim 3 , wherein the biopolymeric fibers are 50 to 500 cm in length.

5. The sheet membrane of claim 1 , further comprising a bioactive agent.

6. The sheet membrane of claim 1 , wherein the membrane is impermeable to cells and the biopolymeric fibers of the membrane are coacervated biopolymeric fibers.

7. The sheet membrane of claim 1 , wherein the membrane has a thickness of 0.05 to 1.5 mm, a density of 0.1 to 1.2 g/cm 3 , a hydrothermal transition temperature of 45 to 80° C., a suture retention strength of 0.1 to 5 kg, and a tensile strength of 20 to 250 kg/cm 2 .

8. The sheet membrane of claim 7 , wherein the membrane is impermeable to cells and the biopolymeric fibers of the membrane are coacervated biopolymeric fibers.

9. The sheet membrane of claim 7 , wherein the biopolymeric fibers are collagen-based fibers.

10. The sheet membrane of claim 9 , wherein the membrane has a thickness of 0.1 to 0.8 mm, a density of 0.2 to 1.0 g/cm 3 , a hydrothermal transition temperature of 50 to 70° C., a suture retention strength of 0.2 to 2 kg, and a tensile strength of 40 to 100 kg/cm 2 , and is permeable to molecules having molecular weights of 100 to 70,000 daltons.

11. The sheet membrane of claim 9 , wherein the biopolymeric fibers are 30 to 800 cm in length.

12. The sheet membrane of claim 11 , wherein the biopolymeric fibers are 50 to 500 cm in length.

13. The sheet membrane of claim 12 , wherein the membrane has a thickness of 0.1 to 0.8 mm, a density of 0.2 to 1.0 g/cm 3 , a hydrothermal transition temperature of 50 to 70° C., a suture retention strength of 0.2 to 2 kg, and a tensile strength of 40 to 100 kg/cm 2 , and is permeable to molecules having molecular weights of 100 to 70,000 daltons.

14. The sheet membrane of claim 13 , wherein the membrane is impermeable to cells and the biopolymeric fibers of the membrane are coacervated biopolymeric fibers.

15. The sheet membrane of claim 7 , wherein the membrane has a thickness of 0.1 to 0.8 mm, a density of 0.2 to 1.0 g/cm 3 , a hydrothermal transition temperature of 50 to 70° C., a suture retention strength of 0.2 to 2 kg, and a tensile strength of 40 to 100 kg/cm 2 , and is permeable to molecules having molecular weights of 100 to 70,000 daltons.

16. The sheet membrane of claim 7 , wherein the biopolymeric fibers are 30 to 800 cm in length.

17. The sheet membrane of claim 16 , wherein the biopolymeric fibers are 50 to 500 cm in length.

18. The sheet membrane of claim 17 , wherein the membrane has a thickness of 0.1 to 0.8 mm, a density of 0.2 to 1.0 g/cm 3 , a hydrothermal transition temperature of 50 to 70° C., a suture retention strength of 0.2 to 2 kg, and a tensile strength of 40 to 100 kg/cm 2 , and is permeable to molecules having molecular weights of 100 to 70,000 daltons.

Assignments (9)
RELEASE OF SECURITY INTEREST Recorded Jan 26, 2026
From: GOLUB CAPITAL MARKETS LLC, AS ADMINISTRATIVE AGENT
To: COLLAGEN MATRIX, INC.
Reel/Frame 073583/0580 →
SECURITY INTEREST Recorded Jan 26, 2026
From: COLLAGEN MATRIX, INC.
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 073583/0614 →
RELEASE OF SECURITY INTEREST IN PATENTS RECORDED AT R/F 049933/0378 Recorded Aug 1, 2024
From: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
To: COLLAGEN MATRIX, INC.
Reel/Frame 068256/0450 →
FIRST LIEN PATENT SECURITY AGREEMENT Recorded Aug 1, 2019
From: COLLAGEN MATRIX, INC.
To: GOLUB CAPITAL, LLC
Reel/Frame 051594/0368 →
SECURITY INTEREST Recorded Aug 1, 2019
From: COLLAGEN MATRIX, INC.
To: THE NORTHWESTERN MUTUAL LIFE INSURANCE COMPANY
Reel/Frame 049933/0378 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Aug 1, 2019
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COLLAGEN MATRIX, INC.
Reel/Frame 049934/0317 →
ASSIGNMENT OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Nov 14, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS RETIRING AGENT
To: HEALTHCARE FINANCIAL SOLUTIONS, LLC, AS SUCCESSOR AGENT
Reel/Frame 037111/0808 →
SECURITY INTEREST Recorded Oct 23, 2014
From: COLLAGEN MATRIX, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 034021/0474 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2005
From: LI, SHU-TUNG; YUEN, DEBBIE; HANSEN, PEGGY
To: COLLAGEN MATRIX, INC.
Reel/Frame 015623/0369 →